Part 1
Part 2
Part 3
Part 4
Part 5
Description
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
The global Formulas for Special Medical Purposes for Diabetes market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Formulas for Special Medical Purposes for Diabetes include Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Formulas for Special Medical Purposes for Diabetes, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Formulas for Special Medical Purposes for Diabetes, also provides the sales of main regions and countries. of the upcoming market potential for Formulas for Special Medical Purposes for Diabetes, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Formulas for Special Medical Purposes for Diabetes sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Formulas for Special Medical Purposes for Diabetes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Formulas for Special Medical Purposes for Diabetes sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, etc.
Market Segmentation
Report Metric
Details
Report Title
Global Formulas for Special Medical Purposes for Diabetes Market Insights, Forecast to 2030
Market Size Available for Years
2024-2030
Global Formulas for Special Medical Purposes for Diabetes Companies Covered
Abbott Laboratories
Nestlé S.A.
NUTRICIA
Fresenius
Ajinomoto
MeadJohnson
BOSSD
Bayer
EnterNutr
Anhui New Health Biotechnology
Bangsidi Biotechnology
Dongze Special Medical Food
Special Biotechnology
Haisike Pharmaceutical
Xi'an Libang Clinical Nutrition
Global Formulas for Special Medical Purposes for Diabetes Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Formulas for Special Medical Purposes for Diabetes Market, Segment by Type
Gel Food
Porous Food
Powdered Food
Pasty Food
Milky Food
Others
Global Formulas for Special Medical Purposes for Diabetes Market, Segment by Application
Hospital
Pharmacy
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Formulas for Special Medical Purposes for Diabetes in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Formulas for Special Medical Purposes for Diabetes manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Formulas for Special Medical Purposes for Diabetes sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Study Coverage
1.1 Formulas for Special Medical Purposes for Diabetes Product Introduction
1.2 Market by Type
1.2.1 Global Formulas for Special Medical Purposes for Diabetes Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Gel Food
1.2.3 Porous Food
1.2.4 Powdered Food
1.2.5 Pasty Food
1.2.6 Milky Food
1.2.7 Others
1.3 Market by Application
1.3.1 Global Formulas for Special Medical Purposes for Diabetes Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Formulas for Special Medical Purposes for Diabetes Sales Estimates and Forecasts 2019-2030
2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region
2.2.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2019-2024)
2.2.3 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2025-2030)
2.2.4 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2019-2030)
2.3 Global Formulas for Special Medical Purposes for Diabetes Sales Estimates and Forecasts 2019-2030
2.4 Global Formulas for Special Medical Purposes for Diabetes Sales by Region
2.4.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2019-2024)
2.4.3 Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2025-2030)
2.4.4 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Manufacturers
3.1.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Manufacturers (2019-2024)
3.1.2 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Formulas for Special Medical Purposes for Diabetes in 2023
3.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Manufacturers
3.2.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Manufacturers (2019-2024)
3.2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Formulas for Special Medical Purposes for Diabetes Revenue in 2023
3.3 Global Key Players of Formulas for Special Medical Purposes for Diabetes, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Formulas for Special Medical Purposes for Diabetes Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Formulas for Special Medical Purposes for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Product Offered and Application
3.8 Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Type
4.1.1 Global Formulas for Special Medical Purposes for Diabetes Historical Sales by Type (2019-2024)
4.1.2 Global Formulas for Special Medical Purposes for Diabetes Forecasted Sales by Type (2025-2030)
4.1.3 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2019-2030)
4.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type
4.2.1 Global Formulas for Special Medical Purposes for Diabetes Historical Revenue by Type (2019-2024)
4.2.2 Global Formulas for Special Medical Purposes for Diabetes Forecasted Revenue by Type (2025-2030)
4.2.3 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2019-2030)
4.3 Global Formulas for Special Medical Purposes for Diabetes Price by Type
4.3.1 Global Formulas for Special Medical Purposes for Diabetes Price by Type (2019-2024)
4.3.2 Global Formulas for Special Medical Purposes for Diabetes Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Application
5.1.1 Global Formulas for Special Medical Purposes for Diabetes Historical Sales by Application (2019-2024)
5.1.2 Global Formulas for Special Medical Purposes for Diabetes Forecasted Sales by Application (2025-2030)
5.1.3 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2019-2030)
5.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application
5.2.1 Global Formulas for Special Medical Purposes for Diabetes Historical Revenue by Application (2019-2024)
5.2.2 Global Formulas for Special Medical Purposes for Diabetes Forecasted Revenue by Application (2025-2030)
5.2.3 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2019-2030)
5.3 Global Formulas for Special Medical Purposes for Diabetes Price by Application
5.3.1 Global Formulas for Special Medical Purposes for Diabetes Price by Application (2019-2024)
5.3.2 Global Formulas for Special Medical Purposes for Diabetes Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Formulas for Special Medical Purposes for Diabetes Market Size by Type
6.1.1 US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2030)
6.1.2 US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2030)
6.2 US & Canada Formulas for Special Medical Purposes for Diabetes Market Size by Application
6.2.1 US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2030)
6.2.2 US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2030)
6.3 US & Canada Formulas for Special Medical Purposes for Diabetes Market Size by Country
6.3.1 US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Country (2019-2030)
6.3.3 US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Formulas for Special Medical Purposes for Diabetes Market Size by Type
7.1.1 Europe Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2030)
7.1.2 Europe Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2030)
7.2 Europe Formulas for Special Medical Purposes for Diabetes Market Size by Application
7.2.1 Europe Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2030)
7.2.2 Europe Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2030)
7.3 Europe Formulas for Special Medical Purposes for Diabetes Market Size by Country
7.3.1 Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2019-2030)
7.3.3 Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Formulas for Special Medical Purposes for Diabetes Market Size
8.1.1 China Formulas for Special Medical Purposes for Diabetes Sales (2019-2030)
8.1.2 China Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030)
8.2 China Formulas for Special Medical Purposes for Diabetes Market Size by Application
8.2.1 China Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2030)
8.2.2 China Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Formulas for Special Medical Purposes for Diabetes Market Size by Type
9.1.1 Asia Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2030)
9.1.2 Asia Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2030)
9.2 Asia Formulas for Special Medical Purposes for Diabetes Market Size by Application
9.2.1 Asia Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2030)
9.2.2 Asia Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2030)
9.3 Asia Formulas for Special Medical Purposes for Diabetes Sales by Region
9.3.1 Asia Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Formulas for Special Medical Purposes for Diabetes Revenue by Region (2019-2030)
9.3.3 Asia Formulas for Special Medical Purposes for Diabetes Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Market Size by Type
10.1.1 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Market Size by Application
10.2.1 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Country
10.3.1 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Nestlé S.A.
11.2.1 Nestlé S.A. Company Information
11.2.2 Nestlé S.A. Overview
11.2.3 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nestlé S.A. Recent Developments
11.3 NUTRICIA
11.3.1 NUTRICIA Company Information
11.3.2 NUTRICIA Overview
11.3.3 NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 NUTRICIA Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 NUTRICIA Recent Developments
11.4 Fresenius
11.4.1 Fresenius Company Information
11.4.2 Fresenius Overview
11.4.3 Fresenius Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Fresenius Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fresenius Recent Developments
11.5 Ajinomoto
11.5.1 Ajinomoto Company Information
11.5.2 Ajinomoto Overview
11.5.3 Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Ajinomoto Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ajinomoto Recent Developments
11.6 MeadJohnson
11.6.1 MeadJohnson Company Information
11.6.2 MeadJohnson Overview
11.6.3 MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 MeadJohnson Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 MeadJohnson Recent Developments
11.7 BOSSD
11.7.1 BOSSD Company Information
11.7.2 BOSSD Overview
11.7.3 BOSSD Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 BOSSD Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BOSSD Recent Developments
11.8 Bayer
11.8.1 Bayer Company Information
11.8.2 Bayer Overview
11.8.3 Bayer Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Bayer Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer Recent Developments
11.9 EnterNutr
11.9.1 EnterNutr Company Information
11.9.2 EnterNutr Overview
11.9.3 EnterNutr Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 EnterNutr Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 EnterNutr Recent Developments
11.10 Anhui New Health Biotechnology
11.10.1 Anhui New Health Biotechnology Company Information
11.10.2 Anhui New Health Biotechnology Overview
11.10.3 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Anhui New Health Biotechnology Recent Developments
11.11 Bangsidi Biotechnology
11.11.1 Bangsidi Biotechnology Company Information
11.11.2 Bangsidi Biotechnology Overview
11.11.3 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bangsidi Biotechnology Recent Developments
11.12 Dongze Special Medical Food
11.12.1 Dongze Special Medical Food Company Information
11.12.2 Dongze Special Medical Food Overview
11.12.3 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dongze Special Medical Food Recent Developments
11.13 Special Biotechnology
11.13.1 Special Biotechnology Company Information
11.13.2 Special Biotechnology Overview
11.13.3 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Special Biotechnology Recent Developments
11.14 Haisike Pharmaceutical
11.14.1 Haisike Pharmaceutical Company Information
11.14.2 Haisike Pharmaceutical Overview
11.14.3 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Haisike Pharmaceutical Recent Developments
11.15 Xi'an Libang Clinical Nutrition
11.15.1 Xi'an Libang Clinical Nutrition Company Information
11.15.2 Xi'an Libang Clinical Nutrition Overview
11.15.3 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Xi'an Libang Clinical Nutrition Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Formulas for Special Medical Purposes for Diabetes Industry Chain Analysis
12.2 Formulas for Special Medical Purposes for Diabetes Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Formulas for Special Medical Purposes for Diabetes Production Mode & Process
12.4 Formulas for Special Medical Purposes for Diabetes Sales and Marketing
12.4.1 Formulas for Special Medical Purposes for Diabetes Sales Channels
12.4.2 Formulas for Special Medical Purposes for Diabetes Distributors
12.5 Formulas for Special Medical Purposes for Diabetes Customers
13 Market Dynamics
13.1 Formulas for Special Medical Purposes for Diabetes Industry Trends
13.2 Formulas for Special Medical Purposes for Diabetes Market Drivers
13.3 Formulas for Special Medical Purposes for Diabetes Market Challenges
13.4 Formulas for Special Medical Purposes for Diabetes Market Restraints
14 Key Findings in The Global Formulas for Special Medical Purposes for Diabetes Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Formulas for Special Medical Purposes for Diabetes Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Gel Food
Table 3. Major Manufacturers of Porous Food
Table 4. Major Manufacturers of Powdered Food
Table 5. Major Manufacturers of Pasty Food
Table 6. Major Manufacturers of Milky Food
Table 7. Major Manufacturers of Others
Table 8. Global Formulas for Special Medical Purposes for Diabetes Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Formulas for Special Medical Purposes for Diabetes Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2019-2024) & (US$ Million)
Table 11. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2025-2030) & (US$ Million)
Table 12. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2019-2024)
Table 13. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2025-2030)
Table 14. Global Formulas for Special Medical Purposes for Diabetes Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2019-2024) & (K Units)
Table 16. Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2025-2030) & (K Units)
Table 17. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2019-2024)
Table 18. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2025-2030)
Table 19. Global Formulas for Special Medical Purposes for Diabetes Sales by Manufacturers (2019-2024) & (K Units)
Table 20. Global Formulas for Special Medical Purposes for Diabetes Sales Share by Manufacturers (2019-2024)
Table 21. Global Formulas for Special Medical Purposes for Diabetes Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 22. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Manufacturers (2019-2024)
Table 23. Global Key Players of Formulas for Special Medical Purposes for Diabetes, Industry Ranking, 2022 VS 2023 VS 2024
Table 24. Formulas for Special Medical Purposes for Diabetes Price by Manufacturers 2019-2024 (US$/Unit)
Table 25. Global Formulas for Special Medical Purposes for Diabetes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Formulas for Special Medical Purposes for Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Formulas for Special Medical Purposes for Diabetes as of 2023)
Table 27. Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Product Offered and Application
Table 29. Global Key Manufacturers of Formulas for Special Medical Purposes for Diabetes, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2024) & (K Units)
Table 32. Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2025-2030) & (K Units)
Table 33. Global Formulas for Special Medical Purposes for Diabetes Sales Share by Type (2019-2024)
Table 34. Global Formulas for Special Medical Purposes for Diabetes Sales Share by Type (2025-2030)
Table 35. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2024) & (US$ Million)
Table 36. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2025-2030) & (US$ Million)
Table 37. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Type (2019-2024)
Table 38. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Type (2025-2030)
Table 39. Formulas for Special Medical Purposes for Diabetes Price by Type (2019-2024) & (US$/Unit)
Table 40. Global Formulas for Special Medical Purposes for Diabetes Price Forecast by Type (2025-2030) & (US$/Unit)
Table 41. Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2024) & (K Units)
Table 42. Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2025-2030) & (K Units)
Table 43. Global Formulas for Special Medical Purposes for Diabetes Sales Share by Application (2019-2024)
Table 44. Global Formulas for Special Medical Purposes for Diabetes Sales Share by Application (2025-2030)
Table 45. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Application (2019-2024)
Table 48. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Application (2025-2030)
Table 49. Formulas for Special Medical Purposes for Diabetes Price by Application (2019-2024) & (US$/Unit)
Table 50. Global Formulas for Special Medical Purposes for Diabetes Price Forecast by Application (2025-2030) & (US$/Unit)
Table 51. US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2024) & (K Units)
Table 52. US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Type (2025-2030) & (K Units)
Table 53. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2024) & (US$ Million)
Table 54. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Type (2025-2030) & (US$ Million)
Table 55. US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2024) & (K Units)
Table 56. US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Application (2025-2030) & (K Units)
Table 57. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2024) & (US$ Million)
Table 58. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Application (2025-2030) & (US$ Million)
Table 59. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Country (2019-2024) & (US$ Million)
Table 61. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue by Country (2025-2030) & (US$ Million)
Table 62. US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Country (2019-2024) & (K Units)
Table 63. US & Canada Formulas for Special Medical Purposes for Diabetes Sales by Country (2025-2030) & (K Units)
Table 64. Europe Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2024) & (K Units)
Table 65. Europe Formulas for Special Medical Purposes for Diabetes Sales by Type (2025-2030) & (K Units)
Table 66. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2024) & (US$ Million)
Table 67. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Type (2025-2030) & (US$ Million)
Table 68. Europe Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2024) & (K Units)
Table 69. Europe Formulas for Special Medical Purposes for Diabetes Sales by Application (2025-2030) & (K Units)
Table 70. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Application (2025-2030) & (US$ Million)
Table 72. Europe Formulas for Special Medical Purposes for Diabetes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 73. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2025-2030) & (US$ Million)
Table 75. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2019-2024) & (K Units)
Table 76. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2025-2030) & (K Units)
Table 77. China Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2024) & (K Units)
Table 78. China Formulas for Special Medical Purposes for Diabetes Sales by Type (2025-2030) & (K Units)
Table 79. China Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2024) & (US$ Million)
Table 80. China Formulas for Special Medical Purposes for Diabetes Revenue by Type (2025-2030) & (US$ Million)
Table 81. China Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2024) & (K Units)
Table 82. China Formulas for Special Medical Purposes for Diabetes Sales by Application (2025-2030) & (K Units)
Table 83. China Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2024) & (US$ Million)
Table 84. China Formulas for Special Medical Purposes for Diabetes Revenue by Application (2025-2030) & (US$ Million)
Table 85. Asia Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2024) & (K Units)
Table 86. Asia Formulas for Special Medical Purposes for Diabetes Sales by Type (2025-2030) & (K Units)
Table 87. Asia Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2024) & (US$ Million)
Table 88. Asia Formulas for Special Medical Purposes for Diabetes Revenue by Type (2025-2030) & (US$ Million)
Table 89. Asia Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2024) & (K Units)
Table 90. Asia Formulas for Special Medical Purposes for Diabetes Sales by Application (2025-2030) & (K Units)
Table 91. Asia Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2024) & (US$ Million)
Table 92. Asia Formulas for Special Medical Purposes for Diabetes Revenue by Application (2025-2030) & (US$ Million)
Table 93. Asia Formulas for Special Medical Purposes for Diabetes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 94. Asia Formulas for Special Medical Purposes for Diabetes Revenue by Region (2019-2024) & (US$ Million)
Table 95. Asia Formulas for Special Medical Purposes for Diabetes Revenue by Region (2025-2030) & (US$ Million)
Table 96. Asia Formulas for Special Medical Purposes for Diabetes Sales by Region (2019-2024) & (K Units)
Table 97. Asia Formulas for Special Medical Purposes for Diabetes Sales by Region (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Type (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Type (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Type (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Type (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Application (2019-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Application (2025-2030) & (K Units)
Table 104. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Application (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Application (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 107. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2019-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2025-2030) & (US$ Million)
Table 109. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Country (2019-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales by Country (2025-2030) & (K Units)
Table 111. Abbott Laboratories Company Information
Table 112. Abbott Laboratories Description and Major Businesses
Table 113. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Abbott Laboratories Recent Developments
Table 116. Nestlé S.A. Company Information
Table 117. Nestlé S.A. Description and Major Businesses
Table 118. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Nestlé S.A. Recent Developments
Table 121. NUTRICIA Company Information
Table 122. NUTRICIA Description and Major Businesses
Table 123. NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. NUTRICIA Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. NUTRICIA Recent Developments
Table 126. Fresenius Company Information
Table 127. Fresenius Description and Major Businesses
Table 128. Fresenius Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Fresenius Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Fresenius Recent Developments
Table 131. Ajinomoto Company Information
Table 132. Ajinomoto Description and Major Businesses
Table 133. Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. Ajinomoto Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Ajinomoto Recent Developments
Table 136. MeadJohnson Company Information
Table 137. MeadJohnson Description and Major Businesses
Table 138. MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. MeadJohnson Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. MeadJohnson Recent Developments
Table 141. BOSSD Company Information
Table 142. BOSSD Description and Major Businesses
Table 143. BOSSD Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. BOSSD Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. BOSSD Recent Developments
Table 146. Bayer Company Information
Table 147. Bayer Description and Major Businesses
Table 148. Bayer Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Bayer Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Bayer Recent Developments
Table 151. EnterNutr Company Information
Table 152. EnterNutr Description and Major Businesses
Table 153. EnterNutr Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. EnterNutr Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. EnterNutr Recent Developments
Table 156. Anhui New Health Biotechnology Company Information
Table 157. Anhui New Health Biotechnology Description and Major Businesses
Table 158. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Anhui New Health Biotechnology Recent Developments
Table 161. Bangsidi Biotechnology Company Information
Table 162. Bangsidi Biotechnology Description and Major Businesses
Table 163. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Bangsidi Biotechnology Recent Developments
Table 166. Dongze Special Medical Food Company Information
Table 167. Dongze Special Medical Food Description and Major Businesses
Table 168. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Dongze Special Medical Food Recent Developments
Table 171. Special Biotechnology Company Information
Table 172. Special Biotechnology Description and Major Businesses
Table 173. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Special Biotechnology Recent Developments
Table 176. Haisike Pharmaceutical Company Information
Table 177. Haisike Pharmaceutical Description and Major Businesses
Table 178. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Haisike Pharmaceutical Recent Developments
Table 181. Xi'an Libang Clinical Nutrition Company Information
Table 182. Xi'an Libang Clinical Nutrition Description and Major Businesses
Table 183. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Xi'an Libang Clinical Nutrition Recent Developments
Table 186. Key Raw Materials Lists
Table 187. Raw Materials Key Suppliers Lists
Table 188. Formulas for Special Medical Purposes for Diabetes Distributors List
Table 189. Formulas for Special Medical Purposes for Diabetes Customers List
Table 190. Formulas for Special Medical Purposes for Diabetes Market Trends
Table 191. Formulas for Special Medical Purposes for Diabetes Market Drivers
Table 192. Formulas for Special Medical Purposes for Diabetes Market Challenges
Table 193. Formulas for Special Medical Purposes for Diabetes Market Restraints
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Formulas for Special Medical Purposes for Diabetes Product Picture
Figure 2. Global Formulas for Special Medical Purposes for Diabetes Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Formulas for Special Medical Purposes for Diabetes Market Share by Type in 2023 & 2030
Figure 4. Gel Food Product Picture
Figure 5. Porous Food Product Picture
Figure 6. Powdered Food Product Picture
Figure 7. Pasty Food Product Picture
Figure 8. Milky Food Product Picture
Figure 9. Others Product Picture
Figure 10. Global Formulas for Special Medical Purposes for Diabetes Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global Formulas for Special Medical Purposes for Diabetes Market Share by Application in 2023 & 2030
Figure 12. Hospital
Figure 13. Pharmacy
Figure 14. Others
Figure 15. Formulas for Special Medical Purposes for Diabetes Report Years Considered
Figure 16. Global Formulas for Special Medical Purposes for Diabetes Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Formulas for Special Medical Purposes for Diabetes Revenue 2019-2030 (US$ Million)
Figure 18. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2019-2030)
Figure 20. Global Formulas for Special Medical Purposes for Diabetes Sales 2019-2030 ((K Units)
Figure 21. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2019-2030)
Figure 22. US & Canada Formulas for Special Medical Purposes for Diabetes Sales YoY (2019-2030) & (K Units)
Figure 23. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe Formulas for Special Medical Purposes for Diabetes Sales YoY (2019-2030) & (K Units)
Figure 25. Europe Formulas for Special Medical Purposes for Diabetes Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China Formulas for Special Medical Purposes for Diabetes Sales YoY (2019-2030) & (K Units)
Figure 27. China Formulas for Special Medical Purposes for Diabetes Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Asia (excluding China) Formulas for Special Medical Purposes for Diabetes Sales YoY (2019-2030) & (K Units)
Figure 29. Asia (excluding China) Formulas for Special Medical Purposes for Diabetes Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales YoY (2019-2030) & (K Units)
Figure 31. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The Formulas for Special Medical Purposes for Diabetes Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. The Top 5 and 10 Largest Manufacturers of Formulas for Special Medical Purposes for Diabetes in the World: Market Share by Formulas for Special Medical Purposes for Diabetes Revenue in 2023
Figure 34. Global Formulas for Special Medical Purposes for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2019-2030)
Figure 36. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2019-2030)
Figure 37. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2019-2030)
Figure 38. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2019-2030)
Figure 40. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2019-2030)
Figure 42. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada Formulas for Special Medical Purposes for Diabetes Revenue Share by Country (2019-2030)
Figure 44. US & Canada Formulas for Special Medical Purposes for Diabetes Sales Share by Country (2019-2030)
Figure 45. U.S. Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2019-2030)
Figure 48. Europe Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2019-2030)
Figure 49. Europe Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2019-2030)
Figure 50. Europe Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2019-2030)
Figure 51. Europe Formulas for Special Medical Purposes for Diabetes Revenue Share by Country (2019-2030)
Figure 52. Europe Formulas for Special Medical Purposes for Diabetes Sales Share by Country (2019-2030)
Figure 53. Germany Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 54. France Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 56. Italy Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 57. Russia Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 58. China Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2019-2030)
Figure 59. China Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2019-2030)
Figure 60. China Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2019-2030)
Figure 61. China Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2019-2030)
Figure 62. Asia Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2019-2030)
Figure 63. Asia Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2019-2030)
Figure 64. Asia Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2019-2030)
Figure 65. Asia Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2019-2030)
Figure 66. Asia Formulas for Special Medical Purposes for Diabetes Revenue Share by Region (2019-2030)
Figure 67. Asia Formulas for Special Medical Purposes for Diabetes Sales Share by Region (2019-2030)
Figure 68. Japan Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 72. India Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America Formulas for Special Medical Purposes for Diabetes Sales Share by Country (2019-2030)
Figure 79. Brazil Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 82. Israel Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries Formulas for Special Medical Purposes for Diabetes Revenue (2019-2030) & (US$ Million)
Figure 84. Formulas for Special Medical Purposes for Diabetes Value Chain
Figure 85. Formulas for Special Medical Purposes for Diabetes Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives InterviewedDescription
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
The global Formulas for Special Medical Purposes for Diabetes market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Formulas for Special Medical Purposes for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Formulas for Special Medical Purposes for Diabetes include Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Formulas for Special Medical Purposes for Diabetes, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Formulas for Special Medical Purposes for Diabetes, also provides the sales of main regions and countries. of the upcoming market potential for Formulas for Special Medical Purposes for Diabetes, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Formulas for Special Medical Purposes for Diabetes sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Formulas for Special Medical Purposes for Diabetes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Formulas for Special Medical Purposes for Diabetes sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, etc.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Formulas for Special Medical Purposes for Diabetes in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Formulas for Special Medical Purposes for Diabetes manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Formulas for Special Medical Purposes for Diabetes sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Related Reports
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
Published: 2024-02-23
Pages: 97
USD 2900.00
(Single User License)
The global market for Formulas for Special Medical Purposes for Diabetes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-03
Pages: 91
USD 2900.00
(Single User License)
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 124
USD 3950.00
(Single User License)
The global Formulas for Special Medical Purposes for Diabetes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 98
USD 4250.00
(Single User License)
The global Formulas for Special Medical Purposes for Diabetes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 170
USD 4900.00
(Single User License)
The global Formulas for Special Medical Purposes for Diabetes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 125
USD 2900.00
(Single User License)
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 122
USD 3950.00
(Single User License)
Special medical foods for diabetes usually define GI ≤55% as low GI foods, 55% to 70% as medium GI foods, and GI ≥70% as high GI foods.
Published: 2024-02-23
Pages: 97
The global market for Formulas for Special Medical Purposes for Diabetes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-03
Pages: 91
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 124
The global Formulas for Special Medical Purposes for Diabetes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 98
The global Formulas for Special Medical Purposes for Diabetes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 170
The global Formulas for Special Medical Purposes for Diabetes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 125
The global market for Formulas for Special Medical Purposes for Diabetes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 122
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database